Early Post-Kidney Transplant Treatment With Roxadustat Ameliorates Anemia and Reduces Blood Transfusion Needs in Inflamed Patients: A Case-Matched Study.

No difference was observed between the two groups in cardiovascular, thromboembolic, or rejection events; a nonsignificant trend for increased infection episodes was noted in the ESA group (Odds ratio 1.81, p = 0.685), which may be partially attributable to the higher proportion of patients with a history of immunological nephropathy in that group (Table 2 ). 4.

also in 5,406 other papers